Scientist.com Launches Unified Innovation Hub ® , Connecting Scientific Thought Leadership with its Award-Winning R&D Orchestration Platform

9.6.2026 13:55:00 CEST | Business Wire | Press Release

Scientist.com, the life science industry’s leading AI-enabled R&D orchestration platform and marketplace for scientific products and services, today announced the launch of its unified Innovation Hub^®, a new digital destination that brings together scientific education, technical content, industry insights and access to Scientist.com’s global supplier network.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609744014/en/

Scientist.com's Innovation Hub centralizes a broad library of expert content designed to help researchers, procurement teams and life science leaders stay current on emerging tools, technologies, methodologies and market trends.

As life science R&D becomes more specialized and data-driven, scientists need faster ways to move from learning about new methods and technologies to identifying the right partners, products and services to advance their work. The Innovation Hub centralizes a broad library of expert content designed to help researchers, procurement teams and life science leaders stay current on emerging tools, technologies, methodologies and market trends.

Historically, researchers seeking to understand new technologies, evaluate potential partners or stay current on industry developments have had to navigate a fragmented digital landscape. Technical webinars, expert perspectives, methodology updates and supplier capabilities were often scattered across multiple sites and channels. Scientist.com’s Innovation Hub addresses this challenge by bringing these resources together in one public ecosystem.

“With the Innovation Hub, we are creating a bridge between scientific knowledge and scientific action,” said Kevin Lustig, Founder and CEO, at Scientist.com. “Researchers can explore expert content, learn about emerging methods and technologies, and then connect directly with the tools, services and suppliers that can help advance their work.”

The Innovation Hub includes more than 1,000 technical webinars from InsideScientific.com, along with specialized thought leadership, blogs and podcasts from HealthEconomics.com, both now brought together within Scientist.com’s digital ecosystem. Together, these resources span the life science continuum, from early discovery and preclinical research through clinical development, health economics, outcomes research and market access.

The launch reflects Scientist.com’s broader mission to empower and connect scientists worldwide by making scientific knowledge, supplier discovery and R&D workflows more accessible, efficient and connected.

To explore the Innovation Hub, visit: https://www.scientist.com/innovation-hub

ABOUT SCIENTIST.COM

Scientist.com is the leading AI-enabled R&D orchestration platform and online marketplace for the life science industry. The platform helps organizations simplify and accelerate scientific purchasing by:

Streamlining access to complex research services, products, technologies and data
Accelerating innovation through faster supplier discovery, competitive bidding and standardized workflows
Supporting compliance through integrated pre-project reviews, approvals and oversight
Connecting scientists with a global network of pre-qualified suppliers offering specialized capabilities across discovery, preclinical, translational, clinical and commercial research workflows

Scientist.com powers secure, private marketplaces for many of the world’s largest pharmaceutical companies and hundreds of biotechnology firms, helping them digitize, harmonize and manage scientific purchasing across the full R&D lifecycle. The company is headquartered in Solana Beach, California, with team members supporting customers and suppliers worldwide.

For more information, visit www.scientist.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260609744014/en/

Contacts

Media Contact:
Sean Preci
Scientist.com
marketing@scientist.com
1-877-644-3044

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 16:50:00 CEST | Press Release

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive

emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 17:12:00 CEST | Press Release

emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead

Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 15:00:00 CEST | Press Release

Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme

EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 15:00:00 CEST | Press Release

European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea

ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 14:00:00 CEST | Press Release

ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom